The presentation videos and slides for speakers’ lectures will be made available from 2 October 2024, provided that the speakers have granted us permission to do so.
Topics
Meeting category
Date(s)
12 Sep 2024
Program Language
English
Meeting type
Virtual Meeting
Mpox Clinical Forum 2024
Related Enduring Materials
Enduring Materials
Thursday, 12 September 2024 - 16:00
Dimie Ogoina, MBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSA
16:05 CEST / 10:05 EDT
Overview of the Current Upsurge of Mpox in Africa
Niger Delta University Teaching Hospital (NDUTH), Niger Delta University, and Nigerian Infectious Diseases Society, Nigeria
16:25 CEST / 10:25 EDT
Vaccination for Mpox - What Do We Know?
16:45 CEST / 10:45 EDT
Treatment of Mpox
Overview
Image
What's New
-
We are happy to announce that the 2nd edition of the Mpox Clinical Forum was held virtually on 12 September 2024.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
About this Program
For decades, Mpox has persistently affected communities in West and Central Africa, with reports of the disease dating back to the 1970s. Yet, despite its long-standing presence and impact, Mpox has struggled to receive the attention and resources it urgently needs, remaining a neglected tropical disease. The global outbreak that began in 2022 prompted the WHO to declare a Public Health Emergency of International Concern (PHEIC). Although this status was lifted in July 2023, the crisis has persisted.
As of 2024, Mpox has spread to 111 countries across all six WHO regions. On 13 August 2024, the Africa CDC declared Mpox a Public Health Emergency of Continental Security. Just one day later, the WHO reinstated the PHEIC designation for the MPXV clade I outbreak due to a sharp rise in cases.
The situation highlights a significant disparity in global response and resource allocation as many West and Central African countries are struggling with severe outbreaks, exacerbated by limited healthcare resources and considerable underreporting. The resurgence has also raised concerns about potential virus mutations, waning immunity, and the effectiveness of current treatment and vaccine strategies. Given these challenges, there is a pressing need for enhanced clinician education on Mpox, with a focus on updated surveillance and prophylactic strategies.
This program was designed to provide essential training for healthcare providers, drawing on insights from experienced clinicians and presenting the latest data on Mpox management and prevention.
General Information
Who Should Attend?
-Healthcare providers involved in the care of people diagnosed with Monkeypox;
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Microbiologists; and
-Specialized nurses.
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Microbiologists; and
-Specialized nurses.
Learning Objectives
After attending this webinar, participants will be able to:
-Outline our current knowledge of the epidemiology of the Mpox outbreak;
-Categorize the various clinical symptoms for case recognition/definition; and
-Reflect on the therapeutical options for treatment and prevention.
-Outline our current knowledge of the epidemiology of the Mpox outbreak;
-Categorize the various clinical symptoms for case recognition/definition; and
-Reflect on the therapeutical options for treatment and prevention.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the meeting is English. Translation will not be provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Previous Edition
The program of the 1st edition of the Mpox Clinical Forum 2022 can be found here
Support
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in Mpox.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Gabriele Gudaityte at gabriele.gudaityte@amededu.com or call +31 30 230 7140.
